Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide [Phase 3]
Phase 3 trial in multiple myeloma evaluating tandem stem cell transplants with or without bortezomib and thalidomide; the study was terminat…
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse [Phase 3]
A Phase 3 study of tanespimycin (KOS-953) in patients with multiple myeloma at first relapse has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy followed by bone marrow or peripheral stem cell transplantation in patients with …
-
CLINICAL_TRIALS trial_result · 2011-06-21Clinical Trial Update: A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients [Phase 2]
Phase 2 trial update reports safety and effectiveness results for a bortezomib-based combination (bortezomib + doxorubicin hydrochloride + d…
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for intravenous busulfan (Busulfex) in patients with multiple myeloma; the study was terminated an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Dose-escalation Study of Oral CX-4945 [Phase 1]
Phase 1 dose-escalation study of CX-4945 in patients with various cancers is underway, including breast cancer, inflammatory breast cancer, …
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients [Phase 2]
This clinical trial update reports a Phase 2 study of dasatinib in combination with melphalan and prednisone for relapsed or refractory mult…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Two Cycles of PAD Combination by AHCT in MM [Phase 2]
A phase 2 trial assessing two cycles of the PAD regimen given with autologous hematopoietic cell transplantation in multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/Phase 2 safety study evaluating a CXCR4 antagonist in patients with multiple …
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial comparing Vincristine with DOXIL and Dexamethasone versus Vincristine with Doxorubicin and Dexamethasone in newly diagnosed mu…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: A Multiple Myeloma Trial in Patients With Bone Metastases [Phase 4]
Novartis-sponsored Phase 4 trial in multiple myeloma patients with bone metastases has completed and posted results in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma [Phase 3]
This completed Phase 3 trial evaluated the effect of epoetin alfa on anemia in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy [Phase 2]
This is a Phase 2 extension trial to re-treat relapsed or refractory multiple myeloma patients with bortezomib who previously participated i…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating fludarabine, busulfan, and anti-lymphocyte globulin followed by donor stem cell transplant in older patients with h…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 study of bortezomib in relapsed or refractory multiple myeloma completed in Japan.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment [Phase 2]
Phase 2 clinical trial evaluating a regimen of fludarabine, busulfan, antithymocyte globulin, and donor stem cell transplant in patients wit…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of everolimus in relapsed or refractory multiple myeloma has completed; results are reported.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating interferon-gamma or aldesleukin in combination with vaccine therapy for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of samarium-153 lexidronam pentasodium and high-dose melphalan in patients with mu…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: 2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE [Phase 2]
Phase II study evaluating a rapidly recycled high-dose DTPACE regimen in multiple myeloma; the trial completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [Phase 2]
A Phase 2 trial evaluated the combination of interleukin-2 and interferon alfa in adults with metastatic cancer. The study encompassed multi…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse [Phase 2]
A Phase 2 study evaluating high-dose melphalan with total-body irradiation followed by peripheral stem cell transplantation for patients wit…
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Bevacizumab was studied in a Phase 2 trial for relapsed or refractory multiple myeloma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the combination of Samarium-153 lexidronam pentasodium and bortezomib in relapsed or refractory…